SCHEMBL21965378

SCHEMBL21965378

COc1ccc(NC(C)(C)C)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
HPGD P15428 1/20 0.56
LMNA P02545 3/20 0.54
MAPT P10636 3/20 0.54
NPSR1 Q6W5P4 2/20 0.54
HTT P42858 1/20 0.54
GAA P10253 4/20 0.53
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
MAPK1 P28482 1/20 0.51
LPAR1 Q92633 1/20 0.49
CYP1A1 P04798 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP1B1 Q16678 1/20 0.49
TSHR P16473 1/20 0.48
KDM4E B2RXH2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12777750 0.85 KMT2A (0.54) ALDH1A1HPGDLMNAMAPTNPSR1
SCHEMBL17374980 0.81 GAA (0.54) ALDH1A1HPGDLMNAMAPTNPSR1
SCHEMBL12403870 0.79 RAB9A (0.42) ALDH1A1HPGDLMNAMAPTNPSR1
SCHEMBL12403855 0.79 GAA (0.41) ALDH1A1HPGDLMNAMAPTNPSR1
SCHEMBL19194276 0.79 DDB1 (0.41) ALDH1A1HPGDLMNAMAPTNPSR1
SCHEMBL21966922 0.79 MAPT (0.40) ALDH1A1LMNAMAPTNPSR1HTT
SCHEMBL21965773 0.79 TRPV4 (0.47) ALDH1A1MAPTNPSR1GAALPAR1
SCHEMBL29544483 0.79 MAPT (0.47) ALDH1A1HPGDLMNAMAPTNPSR1
SCHEMBL1547457 0.78 ALDH1A1 (0.61) ALDH1A1HPGDLMNAMAPTGAA
SCHEMBL20888798 0.77 LMNA (0.40) ALDH1A1HPGDLMNAMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation C4 THERAPEUTICS, INC. (US) 2023-09-07 US disclosed
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation C4 THERAPEUTICS, INC. (US) 2023-09-07 US disclosed
US-20200140456-A1 N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION C4 THERAPEUTICS, INC. (US) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230279023-A1 N/O-Linked Degrons and Degronimers for Protein Degradation CRBN, CBL, STUB1 ALDH1A1 4548/4885HPGD 4511/4885LMNA 1209/4885
US-20200140456-A1 N/O-LINKED DEGRONS AND DEGRONIMERS FOR PROTEIN DEGRADATION CRBN, CBL, STUB1 ALDH1A1 4548/4885HPGD 4511/4885LMNA 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.